Prestige Consumer Healthcare Inc
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various… Read more
Prestige Consumer Healthcare Inc (PBV) - Total Assets
Latest total assets as of September 2025: €3.44 Billion EUR
Based on the latest financial reports, Prestige Consumer Healthcare Inc (PBV) holds total assets worth €3.44 Billion EUR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Prestige Consumer Healthcare Inc - Total Assets Trend (2014–2025)
This chart illustrates how Prestige Consumer Healthcare Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Prestige Consumer Healthcare Inc - Asset Composition Analysis
Current Asset Composition (March 2025)
Prestige Consumer Healthcare Inc's total assets of €3.44 Billion consist of 13.2% current assets and 86.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 2.9% |
| Accounts Receivable | €202.04 Million | 5.9% |
| Inventory | €147.71 Million | 4.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €2.30 Billion | 67.5% |
| Goodwill | €527.42 Million | 15.5% |
Asset Composition Trend (2014–2025)
This chart illustrates how Prestige Consumer Healthcare Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Prestige Consumer Healthcare Inc's current assets represent 13.2% of total assets in 2025, an increase from 9.9% in 2014.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2025, up from 1.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 82.0% of total assets, a decrease from 87.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 67.5% of total assets.
Prestige Consumer Healthcare Inc Competitors by Total Assets
Key competitors of Prestige Consumer Healthcare Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Prestige Consumer Healthcare Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Prestige Consumer Healthcare Inc generates 0.33x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Prestige Consumer Healthcare Inc generates $6.31 in net profit.
Prestige Consumer Healthcare Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.70 | 3.56 | 2.39 |
| Quick Ratio | 2.51 | 2.10 | 1.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €362.81 Million | € 273.80 Million | € 175.05 Million |
Prestige Consumer Healthcare Inc - Advanced Valuation Insights
This section examines the relationship between Prestige Consumer Healthcare Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.53 |
| Latest Market Cap to Assets Ratio | 0.75 |
| Asset Growth Rate (YoY) | 2.5% |
| Total Assets | €3.40 Billion |
| Market Capitalization | $2.54 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Prestige Consumer Healthcare Inc's assets below their book value (0.75 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Prestige Consumer Healthcare Inc's assets grew by 2.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Prestige Consumer Healthcare Inc (2014–2025)
The table below shows the annual total assets of Prestige Consumer Healthcare Inc from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | €3.40 Billion | +2.53% |
| 2024-03-31 | €3.32 Billion | -1.05% |
| 2023-03-31 | €3.35 Billion | -8.63% |
| 2022-03-31 | €3.67 Billion | +7.04% |
| 2021-03-31 | €3.43 Billion | -2.41% |
| 2020-03-31 | €3.51 Billion | +2.12% |
| 2019-03-31 | €3.44 Billion | -8.50% |
| 2018-03-31 | €3.76 Billion | -3.85% |
| 2017-03-31 | €3.91 Billion | +32.64% |
| 2016-03-31 | €2.95 Billion | +11.61% |
| 2015-03-31 | €2.64 Billion | +47.13% |
| 2014-03-31 | €1.80 Billion | -- |